This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Latest resources

View more
Real World Experience
Practical insights into the experiences of clinicians implementing treatment with EYLEA® (aflibercept) 8 mg in the UK
PP-EYL-GB-3038, November 2025
Patient Materials
Useful, downloadable resources
PP-PF-WHC-IUS-GB-0072, April 2024
Retinal Pioneers Programme
A source of on-demand, educational resources developed in collaboration with national and international thought leaders
PP-EYL-GB-3029, November 2025
Ophthalmology Resources
Access useful, downloadable ophthalmology resources
PP-EYL-GB-3011, October 2025

Events & webinars

View more
Cardiovascular Summit 2025 - ATTR-CM Highlights
Explore the Key Highlights on Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | Beyonttra®▼ (acoramidis)
PP-BEY-GB-0085, November 2025
CV Summit 2025 - Highlights
Register Your Interest for 2026 Here
PP-BEY-GB-0007, November 2025
Kerendia®▼ (finerenone) Short Videos
PP-KER-GB-0566, March 2024
Resources to support prostate cancer patients
A focus on drug-to-drug interactions, managing risk and navigating around psychosexual health.
PP-NUB-GB-2385, June 2025

Learning Zone

View more
Request An Interactive Pharmacist’s Guide
NUBEQA® (darolutamide)
PP-NUB-GB-2388, May 2025
NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide
PP-NUB-GB-2129, March 2025
Urogenital Symptoms and Sexual Difficulties
(5 mins) Often underreported and undertreated symptoms that significantly affect a woman's relationships.
PP-PF-WHC-IUS-GB-0085 October 2024
Musculoskeletal Symptoms, Anxiety, Low Mood and Brain Fog
(4 mins) Causes for musculoskeletal (MSK) symptoms, how menopause can worsen existing anxiety and depression.
PP-PF-WHC-IUS-GB-0084 October 2024

Podcasts

View more
Conversations at ESMO 2025
Considering comorbidities in your mHSPC patients.
PP-NUB-GB-2752, November 2025
Conversations at ESMO 2025
Doublet and triplet therapy in mHSPC – Who is the right patient?
PP-NUB-GB-2751, November 2025
ESMO 2025
NUBEQA® (darolutamide)
PP-NUB-GB-2700, October 2025
Bonus Episode
with All Speakers
PP-EYL-GB-2553, December 2024

Products

View more
Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
Introduction to Angeliq
PP-ANG-GB-0003, October 2025
NUBEQA® (darolutamide)
About NUBEQA
PP-NUB-GB-2538, August 2025
Beyonttra®▼ (acoramidis) - Overview
About Beyonttra
PP-BEY-GB-0001, May 2025
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg
PP-EYL-GB-2793, March 2025

Register with BayerPRO

To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.